Neonatal fecal abundance of Bifidobacterium longum subspecies infantis is not associated with anthropometric outcomes up to 6 months of age in Bangladeshi infants

In a study of generally healthy infants in Dhaka, Bangladesh, neonatal fecal abundance of *Bifidobacterium longum* subspecies *infantis* was found to be unrelated to growth outcomes, diarrhea risk, or hospitalizations up to six months of age, suggesting that promoting early colonization of this bacterium may not improve growth in populations experiencing postnatal faltering.

The Gist

Imagine a baby's gut as a bustling construction site. For years, scientists have suspected that a specific type of helpful worker, a bacterium called Bifidobacterium longum subsp. infantis (or B. infantis for short), is the "foreman" who ensures the building grows strong and tall. This foreman is famous for eating special sugars found in breast milk and turning them into fuel that keeps the site clean and safe.

The big question was: If you have more of these helpful foremen on day one, does the building (the baby) grow bigger and faster?

This paper, conducted by researchers in Dhaka, Bangladesh, decided to test this theory by looking at a large group of healthy babies. Here is what they found, broken down simply:

The Setup: A Crowded Construction Site

The researchers studied 830 babies in Bangladesh. They took stool samples (which are like "progress reports" from the construction site) during the first month of life to count how many B. infantis foremen were present. They also measured the babies' height and weight at 2, 3, and 6 months to see how well they were growing.

In this part of the world, B. infantis is very common. About 63% of the babies had these bacteria in their gut by the end of the first month.

The Discovery: The Foreman Doesn't Dictate the Growth

The researchers expected to see a pattern: babies with a "high count" of B. infantis should be taller and heavier than those with a "low count."

The result? No connection at all.

It's as if they checked the construction site logs and found that whether there were 10 foremen or 100 foremen on day one, the building ended up exactly the same size.

• Height: No link between the bacteria count and how tall the baby grew.
• Weight: No link between the bacteria count and how much the baby weighed.
• Sickness: Having more of these bacteria didn't make the babies less likely to get diarrhea or need to go to the hospital.

The "Acid" Connection

The researchers also looked at the "environment" of the gut (specifically the pH level, or how acidic it is). They found that B. infantis does act like a cleaner: when there are more of them, the gut becomes more acidic (lower pH).

However, even though the bacteria changed the acidity, that change in acidity didn't translate to better growth. The "cleaner" did their job, but the "building" didn't get bigger because of it.

Why This Matters (According to the Paper)

In many wealthy countries, babies often don't have these bacteria because of things like C-sections or different diets. Scientists have wondered if giving these bacteria to babies (via probiotics) would help them grow better, especially in places where babies often struggle to grow (a problem called "growth faltering").

This study suggests that in places where B. infantis is already common and babies are generally healthy, simply having more of these bacteria won't fix growth problems.

The authors conclude that the reason babies in these regions grow slower than expected isn't because they lack this specific bacterium. It's likely due to other, larger factors affecting the whole population, not just the number of these specific gut workers.

The Bottom Line

Think of B. infantis as a very popular and helpful employee. This study shows that while they are great at their specific job (cleaning the gut), hiring more of them doesn't automatically make the company (the baby) grow faster. If a baby isn't growing well, the solution probably isn't just adding more of this specific bacterium to their gut.

Technical Summary

Technical Summary: Neonatal Bifidobacterium longum subsp. infantis Abundance and Infant Growth in Bangladesh

Problem Statement
Bifidobacterium longum subsp. infantis (B. infantis) is a specialized early-life gut commensal adapted to metabolize human milk oligosaccharides (HMOs). Its metabolism produces short-chain fatty acids that lower gut pH, inhibit pathogens, and potentially influence host metabolism and immune development. While B. infantis is hypothesized to improve infant growth outcomes, epidemiological evidence remains limited, particularly in low- and middle-income countries (LMICs) where growth faltering is prevalent and B. infantis colonization is common. Previous studies have yielded conflicting results: some suggest positive associations with weight-for-age and weight-for-length z-scores, while others find no association with length-for-age or weight-for-age at 24 months. A critical gap exists in understanding whether neonatal B. infantis abundance drives inter-individual growth variations in populations where postnatal growth faltering is a systemic issue rather than an isolated phenomenon.

Methodology
This study utilized a secondary analysis of data from the "Synbiotics for the Early Prevention of Severe Infections in Infants" (SEPSiS) observational cohort conducted in Dhaka, Bangladesh.

• Cohort: The analysis included 830 generally healthy, mostly term-born infants (93% term) enrolled within 4 days of birth. Infants were excluded if they had major congenital anomalies, required mechanical ventilation, received parenteral antibiotics, or were part of other probiotic trials.
• Exposure: The primary exposure was neonatal B. infantis absolute abundance, quantified via qPCR from stool samples collected between days 0 and 28 of life. For each infant, the mean abundance across all available samples in this window was calculated. Undetectable values were imputed at 2.5 log cells/µg DNA.
• Outcomes: Primary outcomes were anthropometric z-scores: Length-for-age (LAZ), Weight-for-age (WAZ), and Weight-for-length (WLZ) measured at 2, 3, and 6 months. Secondary morbidity outcomes included diarrheal events (days 29–60) and hospitalizations (days 29–180). Stool pH was also measured as a potential mediator.
• Statistical Analysis: Linear regression models were used to estimate associations between neonatal B. infantis abundance and anthropometric outcomes, adjusting for baseline z-scores and covariates including breastfeeding status, sex, mode of delivery, gestational age, antibiotic exposure, maternal BMI, education, age, household asset index, and enrollment site. Modified Poisson regression was used for morbidity outcomes. Sensitivity analyses explored different abundance definitions (e.g., categorical detectable/undetectable, area under the curve) and restricted subsets of the cohort.

Key Results

• Colonization Patterns: Neonatal B. infantis abundance exhibited a bimodal distribution. Of the 830 infants, 63% had detectable B. infantis by day 28. The median abundance among detectable infants was 6.4 log cells/µg DNA, while undetectable infants were assigned the imputed value of 2.5 log cells/µg DNA.
• Growth Associations: There was no significant association between neonatal B. infantis abundance and LAZ, WAZ, or WLZ at 2, 3, or 6 months of age. Adjusted models showed null results across all time points (e.g., at 6 months, the difference in LAZ per 1 log cell/µg increase was 0.0073, 95% CI: -0.022 to 0.037, p=0.6).
• Morbidity Associations: Neonatal B. infantis abundance was not associated with the risk of diarrhea (adjusted RR = 0.96, p=0.5) or hospitalization (adjusted RR = 1.0, p>0.9) in the first 6 months.
• Stool pH: While higher B. infantis abundance was significantly associated with lower stool pH (a decrease of 0.093 pH units per log unit increase), neonatal stool pH itself showed no significant association with anthropometric outcomes after covariate adjustment and correction for multiple testing.
• Sensitivity Analyses: A subset analysis restricted to infants with more frequent sampling (schedules A/B) initially showed a positive association with LAZ at 3 months and a negative association with WLZ at 2 months; however, these associations were attenuated and non-significant by 6 months and were not driven by sample size differences.

Significance and Claims
The authors conclude that in a cohort of generally healthy infants in Dhaka, Bangladesh, neonatal abundance of B. infantis is not associated with linear or ponderal growth outcomes up to 6 months of age, nor with risks of diarrhea or hospitalization.

The paper posits that while B. infantis may explain inter-individual variations in growth within specific contexts, it is unlikely to be a primary driver of the population-level growth faltering observed in LMICs, where the entire anthropometric distribution is shifted downward. Given the high prevalence of natural B. infantis colonization in these settings and the lack of observed growth benefits, the authors suggest that interventions aimed at promoting early B. infantis colonization (such as probiotic administration) are unlikely to improve growth outcomes in generally healthy infants in populations with widespread postnatal growth faltering. The study emphasizes that growth faltering in these contexts is likely driven by factors beyond the abundance of this specific commensal species.